Paul Tudor Jones’s Sana Biotechnology SANA Stock Holding History

Paul Tudor Jones’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Sell	87,892 -45,291	-34%	-$146K	﹤0.01%	3109
2026 Q1	$384K	Buy	+133,183	New	+$525K	﹤0.01%	2991
2025 Q3	–	Sell	-111,311	Closed	-$304K	–	3817
2025 Q2	$304K	Buy	+111,311	New	+$230K	﹤0.01%	2875
2024 Q3	–	Sell	-51,974	Closed	-$284K	–	3054
2024 Q2	$284K	Buy	+51,974	New	+$414K	﹤0.01%	2030
2023 Q4	–	Sell	-97,240	Closed	-$376K	–	2832
2023 Q3	$376K	Buy	+97,240	New	+$523K	﹤0.01%	1819

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Paul Tudor Jones's SANA Position: Q2 2026 in Review

Paul Tudor Jones reduced its Sana Biotechnology (SANA) stake by 34% in Q2 2026, selling an estimated $146K and leaving 87,892 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

Paul Tudor Jones first reported a position in SANA in Q3 2023 and has held it in 5 quarters since. The position peaked at $384K in Q1 2026. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Paul Tudor Jones held 87,892 shares of Sana Biotechnology worth $307K as of Q2 2026.
Paul Tudor Jones sold 45,291 Sana Biotechnology shares in Q2 2026, an estimated $146K.
Sana Biotechnology made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3109 holding.
Paul Tudor Jones first reported a position in Sana Biotechnology in Q3 2023 and has held it in 5 quarters since.
Paul Tudor Jones's Sana Biotechnology position peaked at $384K in Q1 2026.
208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.